ViGenCell Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Kim Tai Gyu
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | 5.1% |
| Management average tenure | 3.5yrs |
| Board average tenure | no data |
Recent management updates
No updates
CEO
Kim Tai Gyu
no data
Tenure
Mr. Kim Tai Gyu, M.D., Ph D., has been Chief Executive Officer of Boryung ViGenCell Inc. He has been Professor of the Catholic University of Korea, College of Medicine. He serves as Director of the Catholi...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Executive Officer | no data | no data | 5.15% ₩ 2.6b | |
| Head of ViTier Platform Group | 4.3yrs | no data | no data | |
| Head of ViRanger Platform Group | 4.3yrs | no data | 0.83% ₩ 420.8m | |
| VP and Head of Business Support Group & Management Administration | no data | no data | 0.33% ₩ 165.7m | |
| Head of Precision Medicine Diagnostics Group & GMP Center | 2.8yrs | no data | no data | |
| Head of ViMedier Platform Group | 1.8yrs | no data | no data |
3.5yrs
Average Tenure
Experienced Management: A308080's management team is considered experienced (3.5 years average tenure).